Lion's Mane for Brain Fog: What the Evidence Shows
Verdict: Mixed. Small, short-term effects in older adults; almost no data in younger adults or for brain fog specifically.
The claim on the label is reasonable-sounding: lion’s mane (Hericium erinaceus) contains compounds called hericenones and erinacines, which in laboratory studies stimulate the synthesis of nerve growth factor [3]. The mechanism is real. The question is whether swallowing those compounds produces meaningful NGF increases in the human brain, and whether those increases translate to cognitive improvement that a person would notice. The supplement industry treats the mechanism as if the question has been answered. The clinical evidence is considerably less certain.
Before evaluating the evidence, the diagnostic reminder: lion’s mane cannot treat hypothyroidism, iron-deficiency anemia, vitamin B12 deficiency, sleep apnea, or depression. These are the causes of brain fog that account for the majority of persistent cases in primary care, and each has a specific, effective treatment that no supplement can replicate. If your brain fog has not been evaluated by a doctor, the supplement is the second thing to try, not the first. See what causes brain fog for the full checklist.
What lion’s mane is
Lion’s mane is an edible mushroom in the genus Hericium, used in traditional East Asian medicine and increasingly marketed in the West as a cognitive supplement. The mushroom has a distinctive cascading white appearance and grows on hardwood trees. It has a long culinary history in China, Japan, and Korea, where it is valued for both flavor and purported medicinal properties.
The compounds of interest for cognition are hericenones (found in the fruiting body) and erinacines (found in the mycelium). In cell cultures and animal studies, these compounds promote NGF synthesis. In mice, lion’s mane supplementation has been associated with hippocampal and cerebellar neurogenesis [4]. This is worth understanding clearly: the animal evidence is for neurogenesis (the growth of new neurons), which is a real and measurable biological process. In rodent models, this translates to improved performance on memory tasks.
The mechanism is plausible. That is not the same as proven. And the distance between “stimulates NGF in a cell culture” and “improves a human’s ability to think through a foggy Tuesday afternoon” is large. Cell cultures do not have blood-brain barriers, absorption rates, or metabolic pathways. Mice are not humans. The mechanism establishes that further research is warranted, not that the supplement works.
What the evidence shows
In older adults with mild cognitive impairment
The best-designed trial is Mori et al. (2009): a double-blind, placebo-controlled RCT in 30 Japanese adults aged 50 to 80 with mild cognitive impairment. Participants took 3 grams of lion’s mane dry powder daily, in tablet form divided into three daily doses, for 16 weeks. The lion’s mane group showed significantly higher scores on a cognitive function scale compared to placebo at weeks 8, 12, and 16 [1].
Two findings matter more than the positive result. First, the sample was small: 30 participants, which means individual variation can substantially distort the outcome. A trial this small can detect only large effects reliably, and the effect observed was not large. Second, when participants were tested four weeks after stopping supplementation, the improvement had completely disappeared. The cognitive gains, such as they were, required ongoing use and did not persist even briefly after cessation. This pattern is consistent with a compound that modulates a temporary state rather than producing lasting neurological change.
Saitsu et al. (2019) tested a slightly higher dose, 3.2 grams daily, in 31 healthy Japanese adults over 50 for 12 weeks and found small improvements on a limited cognitive battery [2]. The participants in this trial did not have diagnosed cognitive impairment, which makes the finding more relevant to the general consumer, but the study shares the same limitations: small sample, short duration, and no follow-up after cessation. Whether the improvements would persist, grow, or plateau with longer use is unknown.
In younger healthy adults
This is the population that makes up most of the supplement market for lion’s mane, and the evidence here is thinnest.
Docherty et al. (2023) tested 1.8 grams daily in 41 healthy adults aged 18 to 45 for 28 days [5]. The study found an improvement in a specific reaction-time task (a speed-of-processing measure) but not in broader cognitive measures including memory, attention, and executive function. The dose was lower than the older-adult trials, the duration was shorter, and the population was fundamentally different. Younger, cognitively healthy adults have less room for measurable improvement, which makes detecting small effects harder. But it also means the practical benefit, even if real, would be smaller. A healthy 28-year-old’s cognitive ceiling is higher than a 70-year-old’s with mild impairment, and the distance a supplement can move them is correspondingly narrower.
For brain fog specifically
There are no published clinical trials testing lion’s mane for brain fog as a primary outcome. This is the central gap in the evidence, because brain fog is the reason most people are buying the supplement. The existing trials measure cognitive function on standardized tests in specific populations. Whether their results extend to the broader, subjective experience of brain fog, which can be caused by thyroid dysfunction, anemia, depression, sleep deprivation, long COVID, or a dozen other conditions that have nothing to do with NGF, is unknown. A supplement that produces a small improvement on a cognitive test in an older adult with mild impairment may be entirely irrelevant to a 35-year-old whose fog is caused by iron deficiency or undiagnosed sleep apnea.
For mood
Preclinical evidence suggests potential antidepressant and anxiolytic effects of lion’s mane, but the clinical evidence is insufficient to draw conclusions [6]. A small number of studies have found reduced anxiety and depression scores in human participants taking lion’s mane, but the trials are small and the outcomes are secondary, not the primary endpoint. Since depression is itself a common cause of brain fog, this line of research is worth watching, but it is not yet evidence of anything actionable.
The product quality problem
Lion’s mane supplements vary considerably in their composition. Some are derived from the fruiting body, others from the mycelium grown on grain substrates. The mycelium-based products may contain substantial amounts of the grain substrate itself, which dilutes the concentration of the active compounds (hericenones from the fruiting body, erinacines from the mycelium). There is no industry standardization for hericenone or erinacine content, and few manufacturers provide independent third-party testing confirming the presence of these compounds at meaningful concentrations. The clinical trials used specific, often research-grade preparations that may not correspond to what is on the shelf at a supplement store. A consumer purchasing lion’s mane cannot easily verify whether their product matches the preparation used in any specific trial.
Verdict
Mixed. The in vitro mechanism is real: lion’s mane compounds stimulate NGF synthesis in cell cultures and promote neurogenesis in animal models. The human evidence shows small, short-term improvements in cognitive scores in older adults with mild cognitive impairment, which disappear within four weeks of stopping. The evidence in younger healthy adults is thinner, shorter in duration, and shows improvement on only a narrow task rather than broad cognitive function. No trial has tested lion’s mane against placebo for the symptom of brain fog in a general adult population. No trial has tested it for more than 16 weeks. No trial has compared it to an active comparator, such as caffeine, which has stronger evidence for attention at a fraction of the cost.
Lion’s mane is not worthless. The mechanism is plausible, the compound appears safe in the durations tested, and the evidence in older adults with impairment is cautiously positive. But it is not what the label implies, and if your fog is coming from an untreated thyroid condition, poor sleep, or iron deficiency, no amount of mushroom extract will address it. The supplement market’s confidence in lion’s mane is running well ahead of the clinical evidence.
What remains unknown
The biggest gaps: there is no trial longer than 16 weeks, so whether benefits accumulate, plateau, or diminish with extended use is unknown. The finding from Mori et al. that effects disappeared within four weeks of stopping raises the possibility that the compound requires continuous use, which makes the absence of long-term data more concerning, not less: a supplement you need to take indefinitely should have evidence for safety and efficacy beyond four months. There is no trial in adults with post-COVID brain fog, the population most actively seeking new interventions. There is no trial comparing lion’s mane to any active comparator, which means we do not know whether it performs better, worse, or identically to caffeine, omega-3, or any other supplement with a plausible cognitive claim. The dose-response relationship is unclear because different trials used different preparations (whole fruiting body, mycelium extract, standardized hericenone content) at different doses (1.8g to 3.2g daily). Whether the erinacines in mycelium-based supplements cross the blood-brain barrier in meaningful amounts in humans is still debated; the absorption and bioavailability data comes primarily from animal models. Whether the specific products on supplement shelves contain the active compounds at the concentrations found in the research preparations is not guaranteed, because lion’s mane supplements are not standardized to a consistent hericenone or erinacine content. A product made from mycelium grown on grain may contain substantial amounts of starch filler and very little of the bioactive compounds found in the fruiting body, and the label may not distinguish between these. The consumer is left trusting the manufacturer’s claims about a product whose active ingredient content is neither regulated nor independently verified.
If brain fog is new, persistent, or affecting daily life. See a doctor. Brain fog can be caused by conditions that are straightforward to treat once identified, including thyroid disorders, anemia, sleep apnea, and depression. A blood panel and a conversation with a GP is the first step, before any supplement.
Frequently asked questions
Does lion's mane actually help with brain fog?
There is no direct clinical evidence for lion's mane specifically treating brain fog. The existing trials tested cognitive function in older adults with mild cognitive impairment, not brain fog as a symptom. A 2009 Japanese trial of 30 older adults found improved cognitive scores after 16 weeks, but the effect disappeared after stopping [[1]](#source-1).
How long does lion's mane take to work?
In the trials that found effects, improvements appeared between 8 and 16 weeks. Effects did not persist after supplementation stopped, suggesting ongoing use would be required to maintain any benefit [[1]](#source-1).
What dose of lion's mane was used in studies?
The Mori et al. 2009 trial used 3 grams per day of lion's mane dry powder (in tablet form) divided into three doses. Other trials have used extracts at varying concentrations, making direct dose comparison difficult.
Is lion's mane safe?
In the available clinical trials (up to 16 weeks), lion's mane was generally well tolerated with no serious adverse events reported. However, long-term safety data in humans is limited [[1]](#source-1).
Is lion's mane better than other nootropics for brain fog?
The evidence does not support ranking lion's mane above better-studied nootropics such as caffeine plus L-theanine, which has more robust evidence for attention and focus in healthy adults. Lion's mane's evidence base is smaller and more preliminary.
Sources and further reading
- Mori et al. -- Improving effects of the mushroom Yamabushitake on mild cognitive impairment
Phytotherapy Research, 2009. Double-blind RCT in 30 Japanese adults (50-80 years) with mild cognitive impairment. 3g/day for 16 weeks. Significant improvement on cognitive function scale vs placebo. Effect disappeared 4 weeks after cessation.
- Saitsu et al. -- Improvement of cognitive functions by oral intake of Hericium erinaceus
Biomedical Research, 2019. RCT in 31 healthy Japanese adults (50+ years). 3.2g/day for 12 weeks. Small improvements in a limited cognitive battery. Small sample, no follow-up after cessation.
- Li et al. -- Hericium erinaceus: an edible mushroom with medicinal values
Journal of Restorative Medicine, 2014. Review of lion's mane pharmacology including hericenones and erinacines. Covers in vitro evidence for NGF stimulation. Notes the gap between in vitro and clinical evidence.
- Ratto et al. -- Hericium erinaceus Improves Recognition Memory and Induces Hippocampal and Cerebellar Neurogenesis
Journal of Medicinal Food, 2019. Animal study (mice). Found neurogenesis in hippocampus and cerebellum. Useful for mechanism but not evidence of human clinical effect.
- Docherty et al. -- The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function
Nutrients, 2023. RCT in 41 healthy adults (18-45 years). 1.8g/day for 28 days. Found improvements in a specific reaction-time task but not in other cognitive measures. Small sample, short duration.
- Chong et al. -- Therapeutic Potential of Hericium erinaceus for Depressive Disorder
International Journal of Molecular Sciences, 2020. Review of preclinical and limited clinical evidence for antidepressant and anxiolytic effects. Notes insufficient clinical trial data.
Sources checked July 4, 2025. This is an editorial summary, not a systematic review or individual advice.